Salestools LogoSalestools
Agents IA Salestools
Solutions
Ressources
Entreprise
Tarifs
Salestools Logo

Salestools

L'agent IA #1 pour les équipes de vente et Go-to-Market. Vendez plus, plus vite, avec moins d'effort.

Produit

  • Agents de vente IA
  • Données d'intention
  • Données technologiques
  • Suivi des visiteurs
  • Copilote
  • Vente sociale

Solutions

  • Service client
  • E-commerce
  • SaaS
  • Entreprise
  • Petite entreprise

Ressources

  • Le rapport
  • Documentation
  • Référence API
  • Centre d'aide
  • Blog
  • Études de cas
  • Webinaires

Entreprise

  • À propos
  • Carrières
  • Presse
  • Contact
  • Partenaires

Nos bureaux

  • New York, HQ
  • Bucarest, Laboratoire de recherche IA
  • Zug, Suisse

© 2025 Salestools. Tous droits réservés.

Conditions relatives aux données et sécuritéPolitique de confidentialitéConditions de service
Tous les systèmes opérationnels
Salestools LogoSalestools
Agents IA Salestools
Solutions
Ressources
Entreprise
Tarifs
Back to The Report
Fundraising

Athelas

Athelas Raises $132M in Series C

2016
Founded
300+
Employees
Mountain View, CA
Updated October 13, 2021
2 min read

Quick Facts

Athelas Raises $132M in Series C


Athelas has successfully raised $132M in a Series C at a $1.5B valuation led by General Catalyst, Tribe Capital.


Company Overview


Athelas is a HealthTech company headquartered in Mountain View, CA, founded in 2016 with 300+ employees.


Remote patient monitoring and automation


Fundraising Details


  • Amount Raised: $132M
  • Round Type: Series C
  • Valuation: $1.5B
  • Date: 2021-10-13
  • Investors: General Catalyst, Tribe Capital

About Athelas


Remote patient monitoring and automation The company is positioned in the HealthTech sector, serving a growing market with innovative solutions.


Key Information


  • Headquarters: Mountain View, CA
  • Founded: 2016
  • Team Size: 300+
  • Industry: HealthTech

What This Means


This funding round demonstrates strong investor confidence in Athelas's vision and execution. The capital will likely be used to:


  • Scale Operations: Expand the team and operational capacity
  • Product Development: Enhance existing products and develop new features
  • Market Expansion: Enter new markets and strengthen presence in existing ones
  • Technology Investment: Invest in infrastructure and technology capabilities

Industry Context


The HealthTech sector continues to attract significant investment as companies innovate to meet evolving market demands. Athelas's successful fundraising reflects the strong fundamentals and growth potential in this space.


Valuation Milestone


Reaching a $1.5B valuation marks an important milestone for Athelas, positioning the company among notable players in the HealthTech industry.


Looking Ahead


With this new capital, Athelas is well-positioned to execute on its growth strategy and continue building innovative solutions in the HealthTech space. The company's trajectory will be one to watch as it deploys this funding to achieve its next phase of growth.


This fundraising news was reported on 2021-10-13. For more information about Athelas, visit their headquarters at Mountain View, CA.

Topics

Fundraising(2912)HealthTech(503)Series C(291)Athelas

About the Author

Fundraising News Team
Fundraising News Team
Tracking the latest funding rounds and investment news

Related Company Reports

Fundraising
Harvey AI

Harvey AI Raises $160 million in Series F

Harvey AI, a AI Software company based in San Francisco CA, has raised $160 million in Series F at a $8 billion valuation led by Andreessen Horowitz.

Market Intelligence Team
Market Intelligence Team
Dec 4, 2025
0 min read•160 million
Fundraising
7AI

7AI Raises $130 million in Series A

7AI, a Cybersecurity company based in Boston MA, has raised $130 million in Series A at a $700 million valuation led by Index Ventures.

Market Intelligence Team
Market Intelligence Team
Dec 4, 2025
0 min read•130 million
Fundraising
TRIANA Biomedicines

TRIANA Biomedicines Raises $120 million in Series B

TRIANA Biomedicines, a Biotechnology company based in Lexington MA, has raised $120 million in Series B at a Undisclosed led by Ascenta Capital.

Market Intelligence Team
Market Intelligence Team
Dec 3, 2025
0 min read•120 million